The fourth annual Cheek Week, an effort to include more blood stem cell donors in the Be The Match…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) is expected to decide before year’s end on whether or not to approve…
The Committee for Medicinal Products for Human Use (CHMP) is recommending the conditional approval of Adakveo (crizanlizumab) for…
The 5th annual Kier’s Hope 5K Run and Fun Walk — a fundraiser launched by comedian Kier “Junior” Spates…
Hillhurst Biopharmaceuticals announced that the final healthy volunteer has completed the study protocol in a Phase 1 clinical trial…
A Phase 1/2 clinical trial testing Beam Therapeutics’ gene-editing therapy BEAM-101 is continuing to enroll young adults with…
Kier “Junior” Spates is hosting a new podcast to empower and educate people living with sickle cell disease. Called…
Health Canada has approved an extended-release formulation of Ferriprox (deferiprone) to treat iron overload in people with sickle cell…
The U.S. Food and Drug Administration (FDA) has placed a clinical hold on FTX-6058, an experimental therapy that…
The risk of pregnancy-related death is about 26 times higher among people with sickle cell disease (SCD) in the…